patent/UA-48470-C2

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b0bc3616e0ae461081640859023b9484
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-714 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-195 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-205 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-51
filingDate	2001-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db66b9b47efca2a6874c23a78d919621 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6b842c8d80e60485d6a01176f5b2df2
publicationDate	2005-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	UA-48470-C2
titleOfInvention	The biologically active preparation "KARDONAT "
abstract	The biologically active preparation contains as analogue of -butyrobetaine - L-carnitine hydrochloride and the following substances: lysine hydrochloride, coenzyme B12, coenzyme B1, coenzyme B6. The composition may be used for the treatment of cardiovascular diseases and the diseases of the liver.
priorityDate	2001-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526450 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69568 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25199905 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451370833 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1051 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448008838

Total number of triples: 23.